A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
In brief
The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalcoholic steatohepatitis, NASH\]).
Key facts
- Study ID
- NCT06419374
- Run by
- 89bio, Inc.
- People needed
- 762
- Starts
- 2024-05-24
- Expected to finish
- 2031-08-01
- Last updated by the study team
- 2026-08-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- 89bio Clinical Study Site — Sacramento, California, United States (enrolling)
- 89bio Clinical Study Site — Chandler, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Birmingham, Alabama, United States (enrolling)
- 89bio Clinical Study Site — Peoria, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Phoenix, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Sun City, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Tucson, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Homewood, Alabama, United States (enrolling)
- 89bio Clinical Study Site — Tucson, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Little Rock, Arkansas, United States (enrolling)
- 89bio Clinical Study Site — North Little Rock, Arkansas, United States (enrolling)
- 89bio Clinical Study Site — Camarillo, California, United States (enrolling)
- 89bio Clinical Study Site — Canoga Park, California, United States (enrolling)
- 89bio Clinical Study Site — Coronado, California, United States (enrolling)
- 89bio Clinical Study Site — Fountain Valley, California, United States (enrolling)
- 89bio Clinical Study Site — Fresno, California, United States (enrolling)
- 89bio Clinical Study Site — Tucson, Arizona, United States (enrolling)
- 89bio Clinical Study Site — La Jolla, California, United States (enrolling)
- 89bio Clinical Study Site — Los Angeles, California, United States (enrolling)
- 89bio Clinical Study Site — Los Angeles, California, United States (enrolling)
- 89bio Clinical Study Site — Pasadena, California, United States (enrolling)
- 89bio Clinical Study Site — Poway, California, United States (enrolling)
- 89bio Clinical Study Site — Redwood City, California, United States (enrolling)
- 89bio Clinical Study Site — Rialto, California, United States (enrolling)
- 89bio Clinical Study Site — Littleton, Colorado, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.